Can you provide a simple description of Barrett's esophagus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Simple Description of Barrett's Esophagus

Barrett's esophagus is a condition where the normal lining of the lower esophagus (the tube connecting your mouth to your stomach) changes from its usual type to a different type of lining that looks more like what's found in your intestines. 1

What Actually Happens

  • The esophagus normally has a squamous epithelium (flat, layered cells), but in Barrett's esophagus, this gets replaced by columnar epithelium (taller, column-shaped cells) that contains special cells called goblet cells. 1

  • This change is called intestinal metaplasia - essentially, the esophagus develops tissue that resembles intestinal lining. 1

  • This transformation can occur in any length of the esophagus - even short segments (less than 3 cm) count as Barrett's esophagus. 1

Why It Happens

  • Barrett's esophagus develops as a healing response to chronic acid reflux (GERD - gastroesophageal reflux disease). 2, 3

  • When stomach acid repeatedly damages the normal esophageal lining, the body attempts to repair itself by replacing the damaged squamous cells with more acid-resistant columnar cells. 3, 4

  • About 5-15% of people with long-term reflux symptoms will develop Barrett's esophagus, though less than 1% of the general population has it. 1

Why It Matters Clinically

The primary clinical importance is that Barrett's esophagus is a precancerous condition - it's the only known precursor to esophageal adenocarcinoma (a type of esophageal cancer). 1, 5, 6

  • The cancer risk is approximately 0.5% per year for patients with Barrett's esophagus - meaning about 1 in 200 patients will develop cancer in any given year. 1

  • The disease typically progresses through stages: Barrett's esophagus → low-grade dysplasia → high-grade dysplasia → adenocarcinoma. 1, 4

  • However, most patients with Barrett's esophagus will never progress to cancer, making risk stratification important. 4, 6

Common Pitfall to Avoid

Not all columnar epithelium in the esophagus qualifies as Barrett's esophagus - only intestinal-type epithelium with goblet cells meets the diagnostic criteria for true Barrett's esophagus that warrants surveillance. 1 Cardia-type epithelium alone does not establish the diagnosis and does not require surveillance. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Barrett's Esophagus: An Updated Review.

Diagnostics (Basel, Switzerland), 2023

Research

Mechanisms and pathophysiology of Barrett oesophagus.

Nature reviews. Gastroenterology & hepatology, 2022

Research

Barrett Esophagus.

Mayo Clinic proceedings, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.